Crossmark

Do we know enough about the effect of low-dose computed tomography screening for lung cancer on survival to act? A systematic review, meta-analysis and network meta-analysis of randomised controlled trials

Crossref DOI link: https://doi.org/10.1186/s41512-019-0067-4

Published Online: 2019-11-28

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Huiqin

Varley-Campbell, Jo

Coelho, Helen

Long, Linda

Robinson, Sophie

Snowsill, Tristan

Griffin, Ed

Peters, Jaime

Hyde, Chris https://orcid.org/0000-0002-7349-0616
Funding

Funding for this research was provided by:

Health Technology Assessment Programme (14/151/07)
License Information

Text and Data Mining valid from 2019-11-28

Version of Record valid from 2019-11-28
More Information

Article History

Received: 21 December 2018

Accepted: 18 October 2019

First Online: 28 November 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: PenTAG is funded by the UK NIHR to provide academic support to UK policy making bodies such as NICE and the UK National Screening Committee. We do not consider this to be a conflict of interest. There are no other conflicts of interest.

Document is current

Any future updates will be listed below